2001/660/EC: Commission Decision of 6 August 2001 updating Decision 2000/112/EC with regard to distribution between antigen banks of antigen reserves (Text with EEA relevance) (notified under document number C(2001) 2472)

Commission Decision
of 6 August 2001
updating Decision 2000/112/EC with regard to distribution between antigen banks of antigen reserves
(notified under document number C(2001) 2472)
(Text with EEA relevance)
(2001/660/EC)
THE COMMISSION OF THE EUROPEAN COMMUNITIES
,
Having regard to the Treaty establishing the European Community,
Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field(1), as last amended by Council Decision 2001/12/EC(2), and in particular Article 14 thereof,
Having regard to Council Decision 91/666/EEC of 11 December 1991 establishing Community reserves of foot-and-mouth disease vaccines(3), as last amended by Commission Decision 2001/181/EC(4), and in particular Article 7 thereof,
Whereas:
(1) In conformity with Decision 91/666/EEC, the purchase of antigens is a part of the Community action to establish Community reserves of foot-and-mouth disease vaccines.
(2) Annex I to Decision 91/666/EEC details the quantities and subtypes of antigen of the foot-and-mouth disease virus to be stored in Community antigen reserves.
(3) By Commission Decision 93/590/EC(5), as last amended by Decision 2000/112/EC(6), arrangements were made for purchase of A5, A22 and O1 foot-and-mouth disease virus antigens.
(4) By Commission Decision 97/348/EC(7), as last amended by Decision 2000/112/EC, arrangements were made for the purchase of A22-Iraq, C1 and ASIA1 foot-and-mouth disease virus antigens.
(5) By Commission Decision 2000/77/EC(8), arrangements were made for purchase of certain quantities of A Iran 96, A Iran 99, A Malaysia 97, SAT 1, SAT 2 (East African and Southern African strains) and SAT 3 foot-and-mouth disease virus antigen.
(6) By Commission Decision 2000/569/EC(9), arrangements were made for purchase of additional quantities of A22-Iraq, O1-Manisa, ASIA 1-Shamir, A Malaysia 97, SAT 1, SAT 2 (East African and Southern African strains) and SAT 3 foot-and-mouth disease virus antigen.
(7) Following written information from the contractor about the supply and distribution to the approved premises of the antigen purchased in accordance with Decision 2000/569/EC, it appears appropriate to update the Annex to Decision 2000/112/EC detailing the distribution between antigen banks of antigen reserves established within the framework of the Community action concerning reserves of foot-and-mouth disease vaccines and amending Commission Decisions 93/590/EC and 97/348/EC.
(8) The measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Committee,